Alpha 2.0
Login Register
» Articles » PMID: 35352624

Metreleptin for the Treatment of Lipodystrophy: Leading the Way Among Novel Therapeutics for This Unmet Clinical Need

Overview
Journal Curr Med Res Opin
Publisher Informa Healthcare
Specialties General Medicine
Pharmacology
Date 2022 Mar 30
PMID 35352624
Authors
Stergios A Polyzos
Christos S Mantzoros
Affiliations
Soon will be listed here.
Citing Articles

Leptin Reduction as a Required Component for Weight Loss.

Zhao S, Li N, Xiong W, Li G, He S, Zhang Z Diabetes. 2023; 73(2):197-210.

PMID: 37935033 PMC: 10796304. DOI: 10.2337/db23-0571.

The World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC).

Bloomgarden Z J Diabetes. 2023; 15(1):4-6.

PMID: 36610044 PMC: 9870730. DOI: 10.1111/1753-0407.13349.

A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on.

Boutari C, Mantzoros C Metabolism. 2022; 133:155217.

PMID: 35584732 PMC: 9107388. DOI: 10.1016/j.metabol.2022.155217.